Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Vink

Showing results (141-150 of 203) with videos related to

Pageof 21
Sort By:
JNCI Cancer Spectrum|August 10, 2021
Colorectal Cancer Care and Patients' Perceptions Before and During COVID-19: Implications for Subsequent SARS-CoV-2 Infection WavesJeroen W G Derksen, Anne M May, Lonneke V van de Poll-Franse, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 19, 2012
Neuropathological changes in a lamb model of non-accidental head injury (the shaken baby syndrome)J W Finnie, P C Blumbergs, J Manavis, et al.
Cancer Research Communications|February 16, 2024
Cumulative Incidence, Risk Factors, and Overall Survival of Disease Recurrence after Curative Resection of Stage II-III Colorectal Cancer: A Population-based StudyTara C Boute, Hidde Swartjes, Marjolein J E Greuter, et al.
Human Mutation|August 12, 2008
Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice-site prediction programsMaaike P G Vreeswijk, Jaennelle N Kraan, Heleen M van der Klift, et al.
International Journal of Cancer|November 8, 2022
Time-varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population-based study and meta-analysisDave E W van der Kruijssen, Auke J S van der Kuil, Geraldine R Vink, et al.
Cancer Medicine|February 27, 2025
Follow-Up Adherence After Treatment With Curative Intent for Stage II and III Colorectal Cancer PatientsTara C Boute, Rik van Eekelen, Marloes A G Elferink, et al.
Digestive Surgery|July 28, 2021
Role of Up-Front Primary Tumor Resection and Tumor Sidedness in the Survival of Synchronous Metastatic Colon Cancer PatientsDave E W van der Kruijssen, Karlijn L van Rooijen, Sophie A Kurk, et al.
The Annals of Occupational Hygiene|January 24, 2012
Stoffenmanager Nano version 1.0: a web-based tool for risk prioritization of airborne manufactured nano objectsBirgit Van Duuren-Stuurman, Stefan R Vink, Koen J M Verbist, et al.
Anti-Cancer Drugs|November 29, 2007
Alkylphospholipids inhibit capillary-like endothelial tube formation in vitro: antiangiogenic properties of a new class of antitumor agentsShuraila F Zerp, Stefan R Vink, Gerald A Ruiter, et al.
International Journal of Cancer|March 13, 2025
Real-world treatment patterns and outcomes based on RAS/BRAF status in metastatic colorectal cancer-Analysis of the Prospective Dutch Colorectal Cancer cohortSietske C M W van Nassau, Koen Zwart, Frederieke H van der Baan, et al.
Pageof 21

Showing results (141-150 of 203) with videos related to

Sort By:
Pageof 21
JNCI Cancer Spectrum|August 10, 2021
Colorectal Cancer Care and Patients' Perceptions Before and During COVID-19: Implications for Subsequent SARS-CoV-2 Infection WavesJeroen W G Derksen, Anne M May, Lonneke V van de Poll-Franse, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 19, 2012
Neuropathological changes in a lamb model of non-accidental head injury (the shaken baby syndrome)J W Finnie, P C Blumbergs, J Manavis, et al.
Cancer Research Communications|February 16, 2024
Cumulative Incidence, Risk Factors, and Overall Survival of Disease Recurrence after Curative Resection of Stage II-III Colorectal Cancer: A Population-based StudyTara C Boute, Hidde Swartjes, Marjolein J E Greuter, et al.
Human Mutation|August 12, 2008
Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice-site prediction programsMaaike P G Vreeswijk, Jaennelle N Kraan, Heleen M van der Klift, et al.
International Journal of Cancer|November 8, 2022
Time-varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population-based study and meta-analysisDave E W van der Kruijssen, Auke J S van der Kuil, Geraldine R Vink, et al.
Cancer Medicine|February 27, 2025
Follow-Up Adherence After Treatment With Curative Intent for Stage II and III Colorectal Cancer PatientsTara C Boute, Rik van Eekelen, Marloes A G Elferink, et al.
Digestive Surgery|July 28, 2021
Role of Up-Front Primary Tumor Resection and Tumor Sidedness in the Survival of Synchronous Metastatic Colon Cancer PatientsDave E W van der Kruijssen, Karlijn L van Rooijen, Sophie A Kurk, et al.
The Annals of Occupational Hygiene|January 24, 2012
Stoffenmanager Nano version 1.0: a web-based tool for risk prioritization of airborne manufactured nano objectsBirgit Van Duuren-Stuurman, Stefan R Vink, Koen J M Verbist, et al.
Anti-Cancer Drugs|November 29, 2007
Alkylphospholipids inhibit capillary-like endothelial tube formation in vitro: antiangiogenic properties of a new class of antitumor agentsShuraila F Zerp, Stefan R Vink, Gerald A Ruiter, et al.
International Journal of Cancer|March 13, 2025
Real-world treatment patterns and outcomes based on RAS/BRAF status in metastatic colorectal cancer-Analysis of the Prospective Dutch Colorectal Cancer cohortSietske C M W van Nassau, Koen Zwart, Frederieke H van der Baan, et al.
Pageof 21